Amicus Therapeutics Inc. (FOLD)
NASDAQ: FOLD
· Real-Time Price · USD
6.84
-0.84 (-10.94%)
At close: May 01, 2025, 2:43 PM
Amicus Therapeutics Revenue
Amicus Therapeutics reported an annual revenue of $528.29M, reflecting a 32.29% growth. For the quarter ending December 31, 2024, Amicus Therapeutics generated $149.71M in revenue.
Revenue (ttm)
$528.29M
Revenue Growth
32.29%
Price / Sales Ratio
5.43
Revenue / Employee
$1.06M
Employees
499
Market Cap
2.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 528.29M | +32.29% |
| Dec 31, 2023 | 399.36M | +21.30% |
| Dec 31, 2022 | 329.23M | +7.76% |
| Dec 31, 2021 | 305.51M | +17.11% |
| Dec 31, 2020 | 260.89M | n/a |